Bendamustine Accord 25 mg/ml concentrate
Description Bendamustine Accord is an antineoplastic (anti-cancer) medicine that belongs to a group of drugs known as alkylating agents. It works by binding to the DNA of cancer cells while they are reproducing, which interferes with their genetic material and stops cell division. This specific formulation is a clear, colourless to slightly yellow concentrate solution.
Share Now
Additional Information
Product Name Bendamustine Accord 25 mg/ml concentrate
Active Ingredient: Bendamustine hydrochloride.
Description Bendamustine Accord is an antineoplastic (anti-cancer) medicine that belongs to a group of drugs known as alkylating agents. It works by binding to the DNA of cancer cells while they are reproducing, which interferes with their genetic material and stops cell division. This specific formulation is a clear, colourless to slightly yellow concentrate solution.
Indication It is used alone (monotherapy) or in combination with other medicines to treat several types of cancer:
- Chronic Lymphocytic Leukaemia (CLL): First-line treatment (Binet stage B or C) for patients where fludarabine combination chemotherapy is not appropriate.
- Indolent non-Hodgkin’s Lymphomas (NHL): Used as monotherapy for patients who have progressed during or within 6 months of treatment with rituximab or a rituximab-containing regimen.
- Multiple Myeloma: Front-line treatment (Durie-Salmon stage II with progress or stage III) in combination with prednisone for patients older than 65 years who are not eligible for autologous stem cell transplantation and have clinical neuropathy.
Strength 25 mg/ml (vials typically containing 100 mg per 4 ml or 25 mg per 1 ml).
Business Partner Accord Healthcare
Related Products
Related products
Disclaimer
Pharma Solutions is the master distributor for the listed products in Egypt. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.